Traumatic Brain Injury (TBI) Model
If you are looking for reliable and accurate data on traumatic brain injury (TBI) about your compounds, you may be interested to know that Creative Bioarray has established and validated many models of TBI. At Creative Bioarray, we conduct contract research using this model to help you get the most out of your studies. Our team of experts is dedicated to providing you with high-quality data so that you can advance your research with confidence.
Traumatic brain injury (TBI) is a devastating condition that affects both children and adults. It is caused by a variety of factors, including traffic accidents, sports injuries, and accidents on construction sites and during military operations. TBI can lead to a range of disabling conditions, such as impairments in consciousness, speech, physical activity, mental and emotional disorders, and other sequelae, which can have a significant impact on their quality of life. Despite advances in neurosurgical techniques, the rate of disability among TBI survivors has not decreased significantly. Therefore, it is crucial to study the key factors that regulate secondary nerve injury after TBI and identify new targets for improving the prognosis of patients with TBI.
Fig. 1 Common causes of TBI
Our Animal Models of Traumatic Brain Injury (TBI)
To gain insights into the pathological traits of TBI and evaluate potential treatment strategies, various animal models have been established and characterized. At Creative Bioarray, we specialize in providing expertise in the following models of TBI in rodents. These models have been extensively studied and can provide valuable insights into the underlying mechanisms of TBI, as well as potential treatment strategies.
Quotation and Ordering
Equipped with cutting-edge facilities and a team of seasoned scientists, Creative Bioarray is uniquely positioned to assist our clients in selecting the most appropriate model, customizing study-specific protocols and plans, and generating reliable data. Whether the aim is to progress a compound towards out-licensing, expand the therapeutic potential of already approved drugs, or advance a compound to clinical trial stages, Creative Bioarray stands ready to offer support. If you are interested in our services, please do not hesitate to contact us or submit an inquiry to us directly.
Reference
- Beylerli, O., Tamrazov, R., et al. Role of exosomal ncRNAs in traumatic brain injury. Non-coding RNA Research, 2023, 8(4): 686-692.
